Nutritional Growth Solutions Ltd. develops, produces, and sells pediatric protein supplements in the United States and internationally.
Nutritional Growth Solutions Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.18|
|52 Week High||AU$0.17|
|52 Week Low||AU$0.38|
|1 Month Change||-2.63%|
|3 Month Change||-44.78%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-39.34%|
Recent News & Updates
|NGS||AU Personal Products||AU Market|
Return vs Industry: Insufficient data to determine how NGS performed against the Australian Personal Products industry.
Return vs Market: Insufficient data to determine how NGS performed against the Australian Market.
Stable Share Price: NGS is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: NGS's weekly volatility (9%) has been stable over the past year.
About the Company
Nutritional Growth Solutions Ltd. develops, produces, and sells pediatric protein supplements in the United States and internationally. It offers its products under the Healthy Height, Horlicks Growth Plus, and Pro Up brand names. The company was formerly known as N. G. Solutions Ltd.
Nutritional Growth Solutions Fundamentals Summary
|NGS fundamental statistics|
Is NGS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NGS income statement (TTM)|
|Cost of Revenue||US$1.54m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.051|
|Net Profit Margin||-220.79%|
How did NGS perform over the long term?See historical performance and comparison
Is Nutritional Growth Solutions undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate NGS's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate NGS's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: NGS is unprofitable, so we can't compare its PE Ratio to the Global Personal Products industry average.
PE vs Market: NGS is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NGS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NGS is overvalued based on its PB Ratio (6.3x) compared to the AU Personal Products industry average (2.9x).
How is Nutritional Growth Solutions forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nutritional Growth Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Nutritional Growth Solutions performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: NGS is currently unprofitable.
Growing Profit Margin: NGS is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NGS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare NGS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NGS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (23%).
Return on Equity
High ROE: NGS has a negative Return on Equity (-232.1%), as it is currently unprofitable.
How is Nutritional Growth Solutions's financial position?
Financial Position Analysis
Short Term Liabilities: NGS's short term assets ($3.3M) exceed its short term liabilities ($772.0K).
Long Term Liabilities: NGS has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NGS's debt to equity ratio (5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if NGS's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NGS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NGS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 65.9% each year
What is Nutritional Growth Solutions's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NGS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NGS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NGS's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Liron Fendell is Chief Executive Officer & Managing Director at Nutritional Growth Solutions Ltd and serves as the Director since October 28, 2020. She has a passion for nutrition, emerging technology...
Experienced Management: NGS's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Experienced Board: NGS's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: NGS only recently listed within the past 12 months.
Nutritional Growth Solutions Ltd.'s employee growth, exchange listings and data sources
- Name: Nutritional Growth Solutions Ltd.
- Ticker: NGS
- Exchange: ASX
- Founded: 2013
- Industry: Personal Products
- Sector: Household
- Market Cap: AU$21.764m
- Shares outstanding: 117.64m
- Website: https://ngsolutions.co
- Nutritional Growth Solutions Ltd.
- The Meusem Tower
- 4 Berkovich Street
- Tel Aviv
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/20 15:36|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.